Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

American Journal of Gastroenterology

Volumn 94, Issue 10, 1999, Pages 3010-3014

  Daniel, Satyajit ^a   Ben Menachem, Tamir ^a   Vasudevan, Gopikrishnan ^a   Ma, Chan K ^a   Blumenkehl, Mark ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; LIVER ENZYME;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DISEASE MARKER; FATTY LIVER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STEATOSIS;

EID: 0032822946     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01451.x     Document Type: Article

References (32)

1. Hulcrantz R., Glauman H., Lindberg G., et al. liver investigation in 149 patients with moderately elevated activities of serum transaminases. Scan J Gastroenterol. 21:1986;109-113.
2. Friedman L.S., Martin P.L., Muñoz S.J. Liver function tests and the objective evaluation of the patient with liver disease. Zakim D., Boyer T.D. Hepatology A textbook of liver disease . 3rd ed. 1996;818-820 WB Saunders, Philadelphia.
3. Diehl A.M., Goodman Z., Ishak K.G. Alcohol-like disease in nonalcoholics. Gastroenterology. 95:1988;1056-1062.
4. Van Ness M.M., Diehl A.M. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med. 111:1989;473-478.
5. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 55:1980;434-438.
6. Schaffner F., Thaler H., et al. Non alcoholic fatty liver disease. Prog Liver Dis. 8:1986;283-298.
7. Lefkowitch J.H., Schiff E.R., Perrillo R.P., et al. Pathological diagnosis of chronic hepatitis C A multicenter comparative study with chronic Hepatitis B . Gastroenterology. 104:1993;595-603.
8. Itoh S., Youngel T., Kamagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol. 8:1987;650-654.
9. Lee R.G. Nonalcoholic steatohepatitis. A study of 49 patients. Hum Pathol. 20:1989;594-598.
10. Powell E.E., Cooksley W.G.E., Hanson R., et al. The natural history of nonalcoholic steatohepatitis A follow-up study of 42 patients for up to 21 years . Hepatology. 11:1990;74-80.
11. Bacon B.R., Farahvash M.J., Janney C.G., et al. Nonalcoholic steatohepatitis An expanded clinical entity . Gastroenterology. 107:1994;1103-1109.
12. Galambos J.T. Alcoholic liver disease Fatty liver, hepatitis and cirrhosis . Berk J.E. Bockus gastroenterology. 4th ed. 1985;3035-3036 WB Saunders, Philadelphia.
13. Zakim D., Boyer T.D., Montgomery C. Alcoholic liver disease. Zakim D., Boyer T.D. Hepatology A textbook of liver disease . 2nd ed. 1990;846 WB Saunders, Philadelphia.
14. Maddrey W.C. Drug and chemical induced hepatic injury. Berk J.E. Bockus gastroenterology. 4th ed. 1985;2925-2956 WB Saunders, Philadelphia.
15. Teli M.R., James O.F.W. The natural history of nonalcoholic steatohepatitis A follow-up study . Hepatology. 22:1995;1714-1719.
16. Sheth S.G., Gordon F.D., Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 126:1997;137-145.
17. Rogers D.W., Lee C.H., Pound D.C., et al. Hepatitis C does not cause nonalcoholic steatohepatitis. Dig Dis Sci. 37:1992;1644-1647.
18. Galambos J.T., Wills C.E. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology. 74:1978;1191-1195.
19. Wanless R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity An autopsy study with analysis of risk factors . Hepatology. 12:1990;1106-1110.
20. Marabou A.T., Buchwald H., Schwartz M.Z., et al. Hepatic lesions of central pericellular fibrosis in morbid obesity, and after jejunoileal bypass. Am J Clin Pathol. 66:1976;684-691.
21. Haines N.W., Baker A.L., Boyer J.L., et al. Prognostic indicators of hepatic injury followingjejunoileal bypass surgery performed for refractory obesity; a prospective study. Hepatology. 1:1981;161-167.
22. Baldridge A.D., Perez-Atayde A.R., Graeme-Cook F., et al. Idiopathic steatohepatitis in childhood A multicenter retrospective study . J Pediatr. 127:1995;700-704.
23. Moran J.R., Grishan F.K., Halter S.A., et al. Steatohepatitis in obese children A cause of chronic liver dysfunction . Am J Gastroenterol. 78:1983;374-377.
24. Tominaga K., Kurata J.H., Chen Y.K., et al. Prevalence of fatty liver in Japanese children and relationship to obesity An epidemiological ultrasonographic survey . Dig Ds Sc. 9:1995;2002-2009.
25. Peters R.L., Gay T., Reynolds T.B. Post jejunoileal-bypass hepatic disease. Its similarities to alcoholic hepatic disease. Am J Clin Pathol. 63:1975;318-331.
26. Silverman J.F., O'Brien K.F., Long S., et al. Liver pathology in morbidly obese patients with and without diabetes. Am M Gastroenterol. 85:1990;1349-1355.
27. Palmer M., Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 99:1990;1408-1413.
28. Eriksson S., Eriksson K.F., Bondesson L. Nonalcoholic steatohepatitis in obesity A reversible condition . Acta Med Scand. 220:1986;83-88.
29. Keffe E., Adesman P., Stenzel P. Steatosis and cirrhosis in an obese diabetic, resolution of fatty liver by fasting. Dig Dis Sci. 32:1987;441-445.
30. Berkowitz D. Metabolic changes associated with obesity before and after weight reduction. JAMA. 187:1964;103-107.
31. Laurin J., Lindor K., Crippin J., et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol induced steatohepatitis A pilot study . Hepatology. 23:1996;1464-1467.
32. Propst A., Propst T., Judmaier G., et al. Prognosis in nonalcoholic steatohepatitis. Gastroenterology. 108:1995;1607. (letter).